Medtechs Applaud UK Life Sciences Fund But Seek Lowering Of £8M Project Threshold

Separate Scheme For Smaller Investments Would Suit Medtechs

The Life Sciences Innovative Manufacturing Fund, set out in the UK budget last month, is live for applications. More UK medtechs would benefit if the cost threshold were scaled down, the industry argues.

(Shutterstock)

The UK’s new Life Sciences Innovative Manufacturing Fund (LSIMF), a capital grants fund to stimulate and encourage life sciences R&D, is open for applications under its first round. Closing date is 29 November. A further three rounds will open on a quarterly schedule in 2025, and more rounds may follow.

The £520m ($670m) fund is aimed at accelerating affordable access to mature, new and emerging products for pandemic and non-pandemic need. It was broadly welcomed when announced in the UK...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from United Kingdom

More from Policy & Regulation

Inclusive By Design: UK Invites Sponsors To Submit Trial Diversity Plans

 
• By 

The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.

Plans For Specific EU Orphan And Pediatric Device Expert Panel Need To Go Further

 

Moves are at last underway for a more specific focus on orphan and pediatric devices. They are a start; but experts are calling for more to support this sector.

First Alzheimer’s Disease Diagnostic Blood Test Cleared By FDA

 

Fujirebio Diagnostics' Alzheimer's disease test, Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, has been cleared by the US FDA.